Vista Pharmaceuticals Ltd (524711) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524711 | NSE: | Pharmaceuticals & Drugs | Small Cap

Vista Pharma Share Price

8.79 0.10 1.15%
as on 05-Dec'25 12:14

Vista Pharmaceuticals Ltd (524711) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524711 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Vista Pharma

Based on:

M-Cap below 100cr DeciZen not available

Vista Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
53.5 Cr.
52-wk low:
7.6
52-wk high:
13.1

Is Vista Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Vista Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vista Pharmaceuticals Ltd is a below average quality company.

2. Is Vista Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Vista Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Vista Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vista Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vista Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vista Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 9.6%8.9%12.4%6.3%-5.2%-5.1%-3.8%-9.6%-8.3%-8.5%-
Value Creation
Index
-0.3-0.4-0.1-0.6-1.4-1.4-1.3-1.7-1.6-1.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 15.424.228.931.122.81.30.4110.310.19
Sales YoY Gr.-57.2%19.6%7.4%-26.8%-94.4%-69.3%156.4%929%-2.1%-
Adj EPS 0.40.50.70-1.3-0.6-0.2-1.5-1-0.8-1.1
YoY Gr.-34.3%48.9%-100%NANANANANANA-
BVPS (₹) 4.56.39119.88.99.68.17.67.47.3
Adj Net
Profit
0.91.320-3.8-2-0.9-5.6-4.5-4.6-7
Cash Flow from Ops. -2.52.6-4.63.30.8-6.8-1-1.7-4.9-7-
Debt/CF from Ops. -3.24.4-2.43.419.3-1.6-12.6-5.8-1.6-1.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -4.6%-15.1%195.6%-2.1%
Adj EPS -208.8%NANANA
BVPS5.7%-5.4%-8.5%-2.4%
Share Price -5.3% 1.5% 3% -25.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
898.40-11.6-6.4-2.5-15.4-11.6-10.8-14.9
Op. Profit
Mgn %
17.712.618.54-21.1-136.6-306.8-386.9-33.4-38.6-79.5
Net Profit
Mgn %
5.65.270-16.6-158.6-215.1-552.7-43.4-45.9-76.5
Debt to
Equity
0.70.70.40.30.50.30.40.30.20.20.1
Working Cap
Days
3322702902873516,40821,7388,671878937346
Cash Conv.
Cycle
9552591532493,97713,5806,49531321345

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 195.57%

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at -0.85%

Latest Financials - Vista Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) -1.1 -
TTM Sales (₹ Cr.) 8.8 -
BVPS (₹.) 7.3 -
Reserves (₹ Cr.) 32 -
P/BV 1.20 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 7.63 / 13.09
All Time Low / High (₹) 0.08 / 56.15
Market Cap (₹ Cr.) 53.5
Equity (₹ Cr.) 12.3
Face Value (₹) 2
Industry PE 40.7

Management X-Ray of Vista Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Vista Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Vista Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales15.3824.1828.9231.0722.761.270.39110.2910.07
Operating Expenses 12.7821.1323.5829.8427.5631.665.3213.8414.10
Manufacturing Costs1.180.931.630.841.850.420.290.381.051.03
Material Costs9.5716.1015.9625.4122.970.730.372.838.898.35
Employee Cost 0.810.700.871.181.311.150.570.511.792
Other Costs 1.223.405.112.401.430.690.431.602.102.72
Operating Profit 2.603.065.341.24-4.80-1.73-1.27-4.32-3.55-4.03
Operating Profit Margin (%) 16.9%12.6%18.5%4.0%-21.1%-136.0%-321.0%-430.0%-34.5%-40.0%
Other Income 0.020.060.402.953.750.200.170.400.330.44
Interest 0.770.881.571.671.541.550.901.341.240.97
Depreciation 1.021.021.341.361.350.730.620.620.720.74
Exceptional Items 0000000000
Profit Before Tax 0.841.222.831.15-3.94-3.81-2.62-5.88-5.18-5.29
Tax 0.06-0.020.640.21-0.26-1.80-1.73-0.21-0.67-0.64
Profit After Tax 0.771.252.190.94-3.68-2.01-0.89-5.66-4.51-4.65
PAT Margin (%) 5.0%5.2%7.6%3.0%-16.2%-158.0%-225.0%-564.0%-43.9%-46.1%
Adjusted EPS (₹)0.30.50.80.3-1.2-0.6-0.2-1.5-1.0-0.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 11.2116.6126.2933.3229.6432.8435.4530.5535.6545.41
Share Capital 55.315.836.076.077.367.367.519.4312.31
Reserves 6.2111.2920.4627.2523.5725.4928.0923.0426.2233.10
Minority Interest0000000000
Debt7.8811.3311.0611.1715.4710.7112.559.967.967.40
Long Term Debt7.886.035.885.965.518.697.435.182.932.38
Short Term Debt05.305.185.219.962.025.134.785.035.02
Trade Payables6.5512.939.135.255.165.115.377.807.415.59
Others Liabilities 0.740.156.232.900.473.94-1.265.073.65-2.49
Total Liabilities 26.3841.0352.7152.6450.7452.6152.1153.3954.6755.92

Fixed Assets

Gross Block18.7414.4720.0224.2425.7225.7225.7426.7627.0627.18
Accumulated Depreciation8.781.022.353.715.065.796.417.027.748.48
Net Fixed Assets 9.9613.4617.6720.5220.6619.9319.3319.7419.3218.70
CWIP 01.997.118.548.789.089.089.339.8210.14
Investments 000.020.030.020.040.030.020.020.05
Inventories2.688.1410.9111.259.689.689.337.686.798.22
Trade Receivables9.749.0110.868.3510.282.1710.4611.254.193.39
Cash Equivalents 0.435.771.790.870.230.140.070.200.090.73
Others Assets 3.572.654.363.081.0911.563.805.1714.4414.69
Total Assets 26.3841.0352.7152.6450.7452.6152.1153.3954.6755.92

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -2.502.57-4.583.300.80-6.75-0.99-1.71-4.91-6.98
PBT 0.841.222.831.15-3.94-3.69-2.62-5.88-5.18-5.29
Adjustment 1.781.882.612.031.912.251.511.831.941.73
Changes in Working Capital -4.93-0.52-10.030.52.83-5.310.121.28-1.68-3
Tax Paid -0.1800-0.380001.050-0.43
Cash Flow From Investing Activity -0.24-3.61-10.61-5.65-1.73-0.30-0.01-1.27-0.79-0.44
Capex -0.25-3.64-10.66-5.65-1.73-0.30-0.01-1.27-0.79-0.44
Net Investments 0000000000
Others 0.010.030.050000000
Cash Flow From Financing Activity 3.076.3611.221.430.286.960.943.115.598.06
Net Proceeds from Shares 03.787.490.240900.769.6114.39
Net Proceeds from Borrowing 7.886.03-0.150.07-0.453.190.67-2.25-2.25-0.55
Interest Paid -0.77-0.88-1.57-1.67-1.54-1.55-0.90-1.21-1.22-0.96
Dividend Paid 0000000000
Others -4.04-2.575.452.792.27-3.681.165.81-0.55-4.81
Net Cash Flow 0.345.32-3.98-0.92-0.64-0.09-0.070.13-0.110.64

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)7.158.9710.193.15-11.68-6.43-2.6-17.16-13.63-11.47
ROCE (%)9.578.9212.426.28-5.2-5.1-3.75-9.58-8.28-8.54
Asset Turnover Ratio0.630.720.620.590.440.020.010.020.190.18
PAT to CFO Conversion(x)-3.252.06-2.093.51N/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days2501421251131491,7945,8433,948274137
Inventory Days34821201301682,7908,7923,092257272
Payable Days273221252103832,5665,213850312284

Vista Pharmaceuticals Ltd Stock News

Vista Pharmaceuticals Ltd FAQs

The current trading price of Vista Pharma on 05-Dec-2025 12:14 is ₹8.79.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Vista Pharma stood at ₹53.49.
The latest P/E ratio of Vista Pharma as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Vista Pharma as of 04-Dec-2025 is 1.20.
The 52-week high of Vista Pharma is ₹13.09 and the 52-week low is ₹7.63.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vista Pharma is ₹8.77 ( Cr.) .

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

The Company was in process of setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.

Vista, the largest division of Torrent Pharmaceuticals Ltd, offers a range of products mainly in the therapeutic areas of gastrointestinal, pain management and anti-infective, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×